Endotherapy Devices Market
By Type;
Gastrointestinal (GI) Devices & Accessories(Biopsy Forceps, Injection Needles, Polypectomy Snares, Graspers, Hemoclips, and Others), Endoscopic Retrograde Cholangio Pancreatography (ERCP) Devices & Accessories(Guide Wire, Sphincterotome, Catheter, Extraction Basket, Extraction Balloon, Balloon Dilation, Plastic Stent, Metal Stents, and Others), OthersBy Application;
Bronchoscopy, Arthroscopy, Laparoscopy, Urology Endotherapy, Neuroendoscopy, Gastrointestinal Endoscopy, and Other.By End-use;
Hospitals, Ambulatory Surgical Centers, and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Endotherapy Devices Market Overview
Endotherapy Devices Market (USD Million)
Endotherapy Devices Market was valued at USD 4,490.16 million in the year 2024. The size of this market is expected to increase to USD 6,445.56 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.3%.
Endotherapy Devices Market
*Market size in USD million
CAGR 5.3 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 5.3 % |
Market Size (2024) | USD 4,490.16 Million |
Market Size (2031) | USD 6,445.56 Million |
Market Concentration | Medium |
Report Pages | 338 |
Major Players
- Stryker
- Boston Scientific Corporation
- Fujifilm
- Conmed Corporation
- Medtronic
- Karl Storz
- Johnson & Johnson Consumer Inc.
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Endotherapy Devices Market
Fragmented - Highly competitive market without dominant players
The Endotherapy Devices Market is expanding rapidly as healthcare providers adopt specialized minimally invasive instruments for targeted interventions. The market has grown by over 37%, driven by demand for efficient systems supporting biopsy, stent delivery, and tissue ablation. This trend guides strategic deployment, allowing clinics to expand therapeutic capabilities and boost procedural precision.
Smart Technologies Elevate Treatment Accuracy
Emerging technological advancements, such as robot-guided catheters, bioabsorbable scaffolds, and needle-system integration, have led to a 39% rise in device uptake. These solutions deliver fine control, shorter procedure times, and reduced complications. Ongoing innovation in endotherapy design is driving improved clinical practice and solidifying growth in target device adoption.
Modular Solutions Offer Clinical Versatility
Demand for customizable endotherapy systems has increased by 35%, reflecting the need for interchangeable toolbeds, precise control settings, and accessory compatibility. Designed to fit varied procedural demands, these modular platforms foster streamlined workflows. This trend in product innovation is boosting efficiency and sustained growth in interventional care.
AI‑Driven Platforms Setting New Standards
About 43% of endotherapy devices now feature AI‑enhanced targeting, digital image overlays, and connected analytics for procedural guidance. These technological advancements equip clinicians with decision support, real‑time metrics, and safety alerts. The move toward smart device platforms is contributing to the future outlook, enabling scalable market expansion and more reliable intervention results.
Endotherapy Devices Market Recent Developments
-
In June 2024, B. Braun announced the launch of its new ACCEL All-Purpose and Biliary Drainage Catheters with TrueGlide Hydrophilic Coating for percutaneous drainage. The catheter featured large oval holes designed to maximize fluid drainage volume, while the TrueGlide Hydrophilic Coating aided in smooth catheter insertion. This product launch was expected to enhance the company's business revenue.
-
In May 2024, Cook Medical launched the next-generation EchoTip AcuCore Endoscopic Ultrasound (EUS) Biopsy Needle in the U.S. The AcuCore needle was designed with a Franseen tip made of a cobalt chromium alloy, allowing physicians to puncture tissue with flexibility, minimal force, and controlled precision. This product launch was expected to enhance the company's product portfolio and offerings to customers.
Endotherapy Devices Market Segment Analysis
In this report, the Endotherapy Devices Market has been segmented by Type, Application, End-use and Geography.
Endotherapy Devices Market, Segmentation by Type
The Endotherapy Devices Market has been segmented by Type into Gastrointestinal (GI) Devices & Accessories, Endoscopic Retrograde Cholangio Pancreatography (ERCP) Devices & Accessories and Other Endotherapy Devices & Accessories.
Gastrointestinal (GI) Devices & AccessoriesThe Gastrointestinal (GI) Devices & Accessories segment dominates the market due to the rising prevalence of gastrointestinal disorders, including colorectal cancer and GERD. These devices are extensively used for diagnostics and therapeutic procedures involving the digestive tract. As of recent estimates, this segment accounts for approximately 45% of the global market share, driven by increasing endoscopic procedures and demand for minimally invasive treatments.
Endoscopic Retrograde Cholangio Pancreatography (ERCP) Devices & AccessoriesERCP Devices & Accessories are vital in diagnosing and treating conditions of the bile ducts and pancreas. Their use has grown steadily with the rise in pancreatobiliary diseases and the demand for therapeutic endoscopy. This segment contributes to nearly 30% of the market, fueled by technological advances such as single-use duodenoscopes and improved imaging tools.
Other Endotherapy Devices & AccessoriesThe Other Endotherapy Devices & Accessories segment includes a range of innovative tools used across multiple specialties, including urology and pulmonology. Although relatively smaller, accounting for around 25% of the market, it is experiencing growth due to expanding clinical indications and emerging markets adopting endoscopic procedures. This segment is expected to grow further as new device launches broaden the scope of endotherapy applications.
Endotherapy Devices Market, Segmentation by Application
The Endotherapy Devices Market has been segmented by Application into Bronchoscopy, Arthroscopy, Laparoscopy, Urology endotherapy, Neuroendoscopy, Gastrointestinal endoscopy and Others.
BronchoscopyBronchoscopy is widely utilized for diagnosing and treating respiratory conditions such as tumors, infections, and airway obstructions. The increasing incidence of lung cancer and chronic respiratory diseases has contributed to its growth. This segment currently accounts for nearly 18% of the market due to the high demand for minimally invasive pulmonary procedures.
ArthroscopyArthroscopy is primarily applied in orthopedic procedures for joint diagnostics and treatments. With a surge in sports-related injuries and osteoarthritis cases, this segment holds significant importance. It contributes approximately 15% to the total market share and continues to grow with technological advances in imaging and instrumentation.
LaparoscopyLaparoscopy dominates the application segment owing to its extensive use in general, bariatric, and gynecological surgeries. The rising preference for minimally invasive surgeries has fueled the segment’s expansion. Laparoscopy represents nearly 30% of the global application share, making it the largest contributor within this segmentation.
Urology EndotherapyUrology Endotherapy includes procedures like ureteroscopy and cystoscopy for managing urological disorders. The increasing prevalence of kidney stones and urinary tract conditions drives this segment’s growth. It holds around 12% of the market and is projected to expand further with improved visualization technologies.
NeuroendoscopyNeuroendoscopy allows surgeons to access and treat brain and spinal cord disorders with minimal invasiveness. Although niche, it is gaining traction with advancements in neurosurgical tools. This segment currently accounts for about 8% of the market, with steady growth expected as awareness and access improve globally.
Gastrointestinal EndoscopyGastrointestinal Endoscopy is used extensively in diagnosing and treating conditions affecting the digestive tract. The rising burden of gastrointestinal diseases, such as colorectal cancer and ulcers, supports its strong market presence. This application holds nearly 15% of the global market share and remains a key revenue driver.
OthersThe Others segment includes applications across lesser-known or emerging areas such as ENT and reproductive health. While smaller in size, this category adds diversity to the market portfolio and enables endotherapy to reach broader clinical fields. It makes up the remaining 2% of the application-based market share.
Endotherapy Devices Market, Segmentation by End-use
The Endotherapy Devices Market has been segmented by End-use into Hospitals, Ambulatory Surgical Centers and Other.
HospitalsHospitals represent the largest end-use segment due to their access to advanced infrastructure, skilled professionals, and high patient volumes. These facilities perform a wide range of endoscopic procedures for diagnostic and therapeutic purposes. This segment accounts for nearly 60% of the market, driven by continuous investments in healthcare technology and the growing burden of chronic diseases.
Ambulatory Surgical CentersAmbulatory Surgical Centers (ASCs) are gaining traction owing to their cost-effectiveness, shorter procedure times, and faster patient recovery. The shift toward outpatient care and minimally invasive techniques fuels demand in this setting. ASCs contribute approximately 30% to the market, with steady growth driven by the increasing volume of elective and day surgeries.
OtherThe Other segment includes diagnostic clinics, specialty centers, and academic institutes involved in endotherapy procedures. Although relatively smaller, accounting for around 10% of the market, this segment plays a crucial role in supporting research, early diagnosis, and community-based care, particularly in emerging economies.
Endotherapy Devices Market, Segmentation by Geography
In this report, the Endotherapy Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Regions and Countries Analyzed in this Report
Endotherapy Devices Market Share (%), by Geographical Region
North AmericaNorth America leads the global endotherapy devices market, accounting for nearly 40% of the total share. The region benefits from high healthcare spending, widespread adoption of minimally invasive procedures, and the presence of key industry players. Technological advancements and favorable reimbursement policies continue to drive market expansion.
EuropeEurope holds the second-largest share in the market, contributing approximately 25%. Countries like Germany, the UK, and France have well-established healthcare systems and rising procedural volumes in endoscopy. Increased focus on early disease detection and patient-centric care supports ongoing growth.
Asia PacificAsia Pacific is emerging as the fastest-growing region, with a current market share of around 20%. Factors such as a rapidly aging population, rising prevalence of gastrointestinal disorders, and improving healthcare infrastructure are fueling demand. Investments by global players in local manufacturing and distribution are further accelerating growth.
Middle East and AfricaMiddle East and Africa hold a relatively smaller share of approximately 8%, but the market is expanding steadily due to increasing awareness, rising medical tourism, and efforts to modernize healthcare systems. Growth is particularly notable in the Gulf Cooperation Council (GCC) countries and South Africa.
Latin AmericaLatin America accounts for about 7% of the global market, with Brazil and Mexico leading adoption. The growing demand for endoscopic procedures, coupled with rising government healthcare initiatives, is helping drive uptake across public and private sectors in the region.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Endotherapy Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Early disease detection boosts demand
- Innovations like capsule endoscopy drive market growth
- Endoscopic ultrasound adoption rises
-
Healthcare pros increasingly recognize endotherapy benefits - Healthcare professionals are increasingly recognizing the benefits of endotherapy as an effective and minimally invasive approach to diagnosing and treating gastrointestinal disorders. Endotherapy offers several advantages over traditional surgical methods, including reduced patient discomfort, shorter recovery times, and lower risk of complications.
Endoscopic procedures enable healthcare providers to visualize internal organs with greater precision, allowing for more accurate diagnoses and targeted treatments. As a result, there is a growing appreciation among healthcare professionals for the versatility and efficacy of endotherapy across a wide range of clinical applications, from routine screenings to complex therapeutic interventions, driving its adoption as a preferred medical intervention in gastroenterology and beyond.
Restraints
- Concerns about post-procedure complications linger
- Accessibility issues persist in remote areas
-
Infection risks with reusable devices pose concerns - Despite its advantages, the use of reusable endotherapy devices raises concerns about the risk of infection transmission and cross-contamination. Healthcare professionals are increasingly mindful of the potential dangers associated with improperly sterilized or inadequately cleaned devices, which can lead to patient harm and healthcare-associated infections.
As a result, there is a growing emphasis on infection control protocols and the adoption of disposable endotherapy devices to mitigate these risks and ensure patient safety. By prioritizing infection prevention measures and investing in single-use devices, healthcare professionals can minimize the likelihood of adverse events and enhance the overall quality of care delivered during endoscopic procedures.
Opportunities
- Customize devices for specific applications
- Develop disposable devices for infection control
- Embrace telemedicine for remote care
-
Diversify into therapeutic endoscopy and surgery - Diversifying into therapeutic endoscopy and surgery presents healthcare professionals with new opportunities to expand their clinical expertise and offer comprehensive care to patients with gastrointestinal conditions. Therapeutic endoscopy involves using endoscopic techniques for therapeutic purposes, such as removing polyps, treating bleeding ulcers, or performing tissue biopsies.
Endoscopic surgery encompasses minimally invasive surgical procedures conducted using specialized endoscopic instruments, offering patients less invasive alternatives to traditional open surgery. By diversifying into these fields, healthcare professionals can broaden their scope of practice, improve patient outcomes, and meet the evolving needs of their patient population, ultimately enhancing the overall quality and efficiency of healthcare delivery in gastroenterology and related specialties.
Competitive Landscape Analysis
Key players in Global Endotherapy Devices Market include
- Stryker
- Boston Scientific Corporation
- Fujifilm
- Conmed Corporation
- Medtronic
- Karl Storz
- Johnson & Johnson Consumer Inc.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By End-use
- Market Snapshot, By Region
- Endotherapy Devices Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Early disease detection boosts demand
- Innovations like capsule endoscopy drive market growth
- Endoscopic ultrasound adoption rises
- Healthcare pros increasingly recognize endotherapy benefits
- Restraints
- Concerns about post-procedure complications linger
- Accessibility issues persist in remote areas
- Infection risks with reusable devices pose concerns
- Opportunities
- Customize devices for specific applications
- Develop disposable devices for infection control
- Embrace telemedicine for remote care
- Diversify into therapeutic endoscopy and surgery
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Endotherapy Devices Market, By Type, 2021 - 2031 (USD Million)
- Gastrointestinal (GI) Devices & Accessories
- Biopsy Forceps
- Injection Needles
- Polypectomy Snares
- Graspers
- Hemoclips
- Others
- Endoscopic Retrograde Cholangio Pancreatography (ERCP) Devices & Accessories
- Guide Wire
- Sphincterotome
- Catheter
- Extraction Basket
- Extraction Balloon
- Balloon Dilation
- Plastic Stent
- Metal Stents
- Others
- Others
- Gastrointestinal (GI) Devices & Accessories
- Endotherapy Devices Market, By Application, 2021 - 2031 (USD Million)
- Bronchoscopy
- Arthroscopy
- Laparoscopy
- Urology endotherapy
- Neuroendoscopy
- Gastrointestinal endoscopy
- Others
-
Endotherapy Devices Market, By End-use, 2021 - 2031 (USD Million)
-
Hospitals
-
Ambulatory Surgical Centers
-
Others
-
- Endotherapy Devices Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Endotherapy Devices Market, By Type, 2021 - 2031 (USD Million)
- Competitive Landscape Analysis
- Company Profiles
- Stryker
- Boston Scientific Corporation
- Fujifilm
- Conmed Corporation
- Medtronic
- Karl Storz
- Johnson & Johnson Consumer Inc.
- Company Profiles
- Analyst Views
- Future Outlook of the Market